![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMiD) drug and an anti-CD38 monoclonal antibody...
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.99 | 3.18808074335 | 62.42 | 64.71 | 60.61 | 343037 | 62.72827692 | CS |
4 | 9.6 | 17.5150519978 | 54.81 | 67.37 | 52.95 | 440950 | 60.37074498 | CS |
12 | 9.72 | 17.7729018102 | 54.69 | 67.37 | 47.88 | 460487 | 55.19569445 | CS |
26 | 4.95 | 8.32492431887 | 59.46 | 75.1 | 47.88 | 460493 | 59.52901488 | CS |
52 | 30.32 | 88.9410384277 | 34.09 | 75.1 | 30.88 | 524114 | 50.74717443 | CS |
156 | 45.41 | 239 | 19 | 75.1 | 6.035 | 471320 | 37.78788389 | CS |
260 | 45.41 | 239 | 19 | 75.1 | 6.035 | 471320 | 37.78788389 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions